Cover image of the article: Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005)

Image Credit:Hepat Mon

Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005)

Authors

Ali Jabbari1, Sima BesharatSima Besharat ORCID2,*, Behnaz Khodabakhshi1
1Deputy of Treatment, Golestan University of Medical Sciences, IR-Iran
2Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, s_besharat_gp@yahoo.com, IR-Iran
*Corresponding Author: Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, s_besharat_gp@yahoo.com, IR-Iran. Tel: +98 171 2240835. Fax: +98 171 2240835. Email: s_besharat_gp@yahoo.com

Hepatitis Monthly:Vol. 8, issue 1; 61-65
Published online:Mar 31, 2008
Article type:Brief Report
Received:Dec 02, 2007
Accepted:Apr 06, 2008
How to Cite:Jabbari A, Besharat S, Khodabakhshi B. Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005). Hepat Mon. 2008;8(1):. doi:

Abstract

Background and Aims: Nosocomial transmission of blood-borne pathogens is common in a dialysis setting. Hepatitis C virus (HCV) infection is a common problem that increases morbidity and mortality in hemodialysis patients. Blood transfusion and the duration of hemodialysis are the most important factors in HCV transmission. The aim of the study was to determine the incidence rate of HCV antibody in hemodialysis patients and its association with some factors.
Methods: In this descriptive-analytical study, HCV antibody was measured in 93 hemodialysis patients in all hospitals affiliated to Golestan University of Medical Sciences. Standard infection prevention measures in hospital settings and dialysis units were performed including serologic testing for HCV antibody for every new patient in the dialysis unit as well as routine testing of all patients. Negative cases of hepatitis C antibody (confirmed with ELISA 2nd generation and RIBA II Immunoblot methods) were selected and followed for 18 months. Some predisposing factors such as transfusion, duration of hemodialysis, medical procedures including surgery, transplantation, invasive odontology, suspicious sexual contact, diagnostic or therapeutic manipulation, tattooing, and IV drug abuse, were registered and considered. Other rare procedures like acupuncture, manicure and pedicure, blood brotherhood rituals, perinatal risk
factors, common circumcision rituals and history of abortion were also considered. We used a tight control policy through the separation of the rooms within the unit, specific hemodialysis apparatus for suspicious patients and a separate staff caring for the patients. We maintained a low rate of staff turnover in dialysis units and tried to control hepatitis B viral infection.
Results: Marital status and living area were significantly related to HCV antibody positivity. It means that more HCV antibody positive cases were observed in married people in urban areas. History of tattooing, medical procedures including surgery, transplantation, invasive odontology and IV drug usage were not significantly related to HCV antibody status. During the follow up, three cases (4.3%) converted to positive. There was a relationship between numbers of hemodialysis per week and HCV antibody positivity (P<0.001).
Conclusions:  Tight control of transmission routes and severe isolation policy in this study explains an almost ideal decrease in incidence rate of HCV antibody positivity. We suggest periodical screening programs (at least every 6 months) for blood samples that remain in the dialysis apparatus and all procedures used for hemodialysis in these specific patients to achieve a better infection control.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2008, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Mar
2004
Prevalence of HCV infection and related risk factors among patients on hemodialysis in Qazvin

Prevalence of HCV infection and related risk factors among patients on hemodialysis in Qazvin

SM Alavian,
J Kafayee,
B Yektaparast,
N Rad,
S Bakhtiari,
B Hajjarizadeh
,et al.

Alavian S, Kafayee J, Yektaparast B, Rad N, Bakhtiari S, et al. Prevalence of HCV infection and related risk factors among patients on hemodialysis in Qazvin. J Inflamm Dis. 2024;7(5):e155001. doi:

28
Jul
2023
Prevalence of Hepatitis C Virus and Its Occult Infection in Hemodialysis Patients

Prevalence of Hepatitis C Virus and Its Occult Infection in Hemodialysis Patients

Mohsen Nakhaie,
Ehsan Taheri,
Javad Charostad,
Nasir Arefinia,
Davood Kalantar-Neyestanaki,
Mohammad Rezaei Zadeh Rukerd
,et al.

Nakhaie M, Taheri E, Charostad J, Arefinia N, Kalantar-Neyestanaki D, et al. Prevalence of Hepatitis C Virus and Its Occult Infection in Hemodialysis Patients. Jundishapur J Microbiol. 2023;16(5):e136504. doi: https://doi.org/10.5812/jjm-136504

19
Dec
2003
Prevalence and  Risk Factors of Hepatitis C infection   in hemodialysis Patients (Kermanshah , 1999 – 2000)

Prevalence and Risk Factors of Hepatitis C infection in hemodialysis Patients (Kermanshah , 1999 – 2000)

B Sabour,
P Boromand,
Y Mehrabi,
M Ghanbari,
H Zarrinfam

Sabour B, Boromand P, Mehrabi Y, Ghanbari M, Zarrinfam H. Prevalence and Risk Factors of Hepatitis C infection in hemodialysis Patients (Kermanshah , 1999 – 2000). J Kermanshah Univ Med Sci. 2003;7(3):e81264. doi:

1
Jun
2014
Risk Factors of HCV Seroconversion in Hemodialysis Patients in Tabriz, Iran

Risk Factors of HCV Seroconversion in Hemodialysis Patients in Tabriz, Iran

Mohammad Hossein Somi,
Jalal Etemadi,
Morteza Ghojazadeh,
Sara Farhang,
Mehrasa Faramarzi,
Sanaz Foroutan
,et al.

Somi MH, Etemadi J, Ghojazadeh M, Farhang S, Faramarzi M, et al. Risk Factors of HCV Seroconversion in Hemodialysis Patients in Tabriz, Iran. Hepat Mon. 2014;14(6):e17417. doi: https://doi.org/10.5812/hepatmon.17417

26
Dec
2021
Prevalence of Hepatitis C Infection and its Genotypes in Suspected Hemodialysis Patients, Southwest of Iran

Prevalence of Hepatitis C Infection and its Genotypes in Suspected Hemodialysis Patients, Southwest of Iran

Marzieh Jamalidoust,
Maryam Eskandari,
Mazyar Ziyaeyan

Jamalidoust M, Eskandari M, Ziyaeyan M. Prevalence of Hepatitis C Infection and its Genotypes in Suspected Hemodialysis Patients, Southwest of Iran. Jundishapur J Microbiol. 2021;14(11):e118591. doi: https://doi.org/10.5812/jjm.118591

More by these authors

Ali JabbariPubMedScholar
Sima BesharatPubMedScholar
Behnaz KhodabakhshiPubMedScholar
Share
Cited by
Metrics